Phocas Financial Corp. Agios Pharmaceuticals, Inc. Transaction History
Phocas Financial Corp.
- $771 Billion
- Q3 2025
A detailed history of Phocas Financial Corp. transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Phocas Financial Corp. holds 46,608 shares of AGIO stock, worth $2.03 Million. This represents 0.24% of its overall portfolio holdings.
Number of Shares
46,608Holding current value
$2.03 Million% of portfolio
0.24%Shares
4 transactions
Others Institutions Holding AGIO
# of Institutions
257Shares Held
63.8MCall Options Held
2.06MPut Options Held
911K-
Farallon Capital Management LLC San Francisco, CA5.78MShares$252 Million1.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.6MShares$245 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$212 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.71MShares$162 Million3.19% of portfolio
-
Erste Asset Management Gmb H Vienna, C42.76MShares$121 Million1.05% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $2.39B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...